PharmaCyte Biotech - Home of Biotechnology
Nuvilex. PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for...
Read Nuvilex.com news digest here: view the latest Nuvilex articles and content updates right away or get to their most visited pages. Nuvilex.com is not yet rated by Alexa and its traffic estimate is unavailable. It seems that Nuvilex content is notably popular in USA. We haven’t detected security issues or inappropriate content on Nuvilex.com and thus you can safely use it. Nuvilex.com is hosted with Amazon Technologies Inc. (United States) and its basic language is English.
- Content verdict: Safe
- Website availability: Stale
- Language: English
- Last check:
-
N/A
Visitors daily -
N/A
Pageviews daily -
3
Google PR -
N/A
Alexa rank
Best pages on Nuvilex.com
-
PharmaCyte Biotech - Home of Biotechnology
PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell ...
Nuvilex.com news digest
-
5 years
PharmaCyte Biotech Selects Medpace as CRO for Its Clinical Trial in Pancreatic C...
LAGUNA HILLS, Calif.–(BUSINESS WIRE)– PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell...
-
5 years
PharmaCyte Biotech Announces Publication of United States Patent Application for...
LAGUNA HILLS, CA, October 30, 2018 (BUSINESS WIRE) — PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation...
-
5 years
PharmaCyte Biotech Announces Publication of PCT Patent Application for Cancer Th...
LAGUNA HILLS, CA, October 9, 2018 (BUSINESS WIRE) — PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology...
-
5 years
PharmaCyte Biotech Reports Completion of Crucial FDA-Required Study for Pancreat...
LAGUNA HILLS, CA, October 1, 2018 (BUSINESS WIRE) — PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology...
Domain history
Web host: | Amazon Technologies Inc. |
Registrar: | TurnCommerce, Inc. DBA NameBright.com |
Registrant: | Domain Admin / This Domain is For Sale (HugeDomains.com) |
Updated: | August 20, 2021 |
Expires: | December 14, 2025 |
Created: | December 14, 2008 |
Whois record
Safety scores
Trustworthiness
N/AChild safety
N/A